Riskpilot← Back to searchSign inGet full accessKMA Medical AB
ABActiveOrg 5593675134Starrbäcksgatan 11 ABeauty care and other beauty treatment activities · NACE 9622Est. 20221-4 employees
Revenue 2025
SEK 8,4M
+22% vs 2024
EBITDA margin
23.3%
+59% vs 2024
Equity ratio
53.8%
Financial strength
Net profit 2025
SEK 1,5M
+73% vs 2024
| Revenue | SEK 8,4M | +22% |
| EBITDA | SEK 2M | +59% |
| Net profit | SEK 1,5M | +73% |
| Total assets | SEK 3,4M | +7% |
| Equity | SEK 1,8M | +91% |
| Employees | — | — |
Legal name
KMA Medical AB
Org number
5593675134
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
25 februari 2022
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamhetens ändamål är att utföra estetiska injektionsbehandlingar, estetiska skönhetsbehandlingar, utbildningar inom estetik, försäljning av skönhetsprodukter och kläder samt därmed förenlig verksamhet.
Address
Starrbäcksgatan 11 A
Email
aksanakanaeva@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 747 | 2 796 | 6 888 | 8 413 |
| Staff expenses | −348 | −781 | −1 987 | −2 345 |
| EBITDA | 66 | 363 | 1 236 | 1 960 |
| Depreciation & amort. | — | −2 | −40 | −100 |
| EBIT | 66 | 361 | 1 196 | 1 860 |
| Net financials | 0 | 1 | −1 | −2 |
| Profit before tax | 66 | 299 | 1 079 | 1 858 |
| Tax | −14 | −68 | −230 | −388 |
| Net profit | 52 | 231 | 849 | 1 470 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 278 | 1 222 | 3 172 | 3 395 |
| Equity | 77 | 308 | 957 | 1 827 |
| Long-term debt | — | — | — | — |
| Short-term debt | 200 | 851 | 2 036 | 1 389 |
| Total debt | 200 | 851 | 2 036 | 1 389 |
EBITDA margin
23.3%
This company
15.8%
Market median
+47% vs market
20222025
Equity ratio
53.8%
This company
38.2%
Market median
+41% vs market
20222025
Return on equity
80.5%
This company
18.4%
Market median
+338% vs market
20222025
Net profit margin
17.5%
This company
8.1%
Market median
+116% vs market
20222025
Asset turnover
2.48×
This company
1.12×
Market median
+121% vs market
20222025
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-25 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NM Chief Auditor | Chief Auditor | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2024 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KMA Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nathalie Melek Lindén | Chief Auditor | 0 companies |
| Natalia Kanaeva | Deputy Board Member | 0 companies |
| Oksana Alexandrovna Kanaeva | Deputy Board Member | 0 companies |
| Marcel Khouri | Board of Directors | 0 companies |